NASDAQ:DYAI Dyadic International (DYAI) Stock Price, News & Analysis → This Wall Street stock prediction just went viral (From Chaikin Analytics) (Ad) Free DYAI Stock Alerts $1.57 +0.08 (+5.37%) (As of 05/15/2024 ET) Add Compare Share Share Today's Range$1.49▼$1.7050-Day Range$1.35▼$1.8752-Week Range$1.19▼$2.40Volume103,813 shsAverage Volume22,585 shsMarket Capitalization$45.91 millionP/E RatioN/ADividend YieldN/APrice Target$6.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Dyadic International alerts: Email Address Dyadic International MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside282.2% Upside$6.00 Price TargetShort InterestBearish0.96% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.43Based on 7 Articles This WeekInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($0.44) to ($0.90) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.43 out of 5 starsMedical Sector742nd out of 928 stocksBiological Products, Except Diagnostic Industry127th out of 153 stocks 3.5 Analyst's Opinion Consensus RatingDyadic International has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageDyadic International has received no research coverage in the past 90 days.Read more about Dyadic International's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted0.96% of the float of Dyadic International has been sold short.Short Interest Ratio / Days to CoverDyadic International has a short interest ratio ("days to cover") of 8.6.Change versus previous monthShort interest in Dyadic International has recently increased by 4.99%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldDyadic International does not currently pay a dividend.Dividend GrowthDyadic International does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DYAI. Previous Next 1.9 News and Social Media Coverage News SentimentDyadic International has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Dyadic International this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for DYAI on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Dyadic International insiders have not sold or bought any company stock.Percentage Held by Insiders28.80% of the stock of Dyadic International is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 27.95% of the stock of Dyadic International is held by institutions.Read more about Dyadic International's insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Dyadic International are expected to decrease in the coming year, from ($0.44) to ($0.90) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Dyadic International is -6.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Dyadic International is -6.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDyadic International has a P/B Ratio of 7.85. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Dyadic International's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Manward PressThis unknown company solves the biggest issue with AINvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in. Discover why this company About Dyadic International Stock (NASDAQ:DYAI)Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health. The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial to demonstrate the safety in humans of a protein produced using the C1 platform. It has also developed the Dapibus thermophilic, a filamentous fungal-based microbial protein production platform to enable the development and large-scale manufacture of cost-effective proteins, metabolites, and other biologic products for use in non-pharmaceutical applications, including food, nutrition, and wellness. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa's Rubic One Health; Joint Development Agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.Read More DYAI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DYAI Stock News HeadlinesMay 15 at 7:40 PM | finance.yahoo.comDYAI: Product Revenues Next YearMay 15 at 7:40 PM | finance.yahoo.comDyadic International Inc (DYAI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review ...May 14 at 9:04 PM | investorplace.comDYAI Stock Earnings: Dyadic International Reported Results for Q1 2024May 14 at 4:36 PM | msn.comDyadic International GAAP EPS of -$0.07, revenue of $0.34MMay 14 at 4:00 PM | globenewswire.comDyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company ProgressMay 14 at 6:15 AM | investing.comDyadic (DYAI) Earnings Dates & ReportsMay 12 at 1:56 AM | americanbankingnews.comDyadic International (DYAI) Set to Announce Earnings on TuesdayMay 8, 2024 | globenewswire.comDyadic to Attend Industry and Investor Events in MayMay 7, 2024 | investing.comDyadic International Inc (DYAI)May 4, 2024 | fool.comDyadic International (NASDAQ: DYAI)April 30, 2024 | globenewswire.comDyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024April 24, 2024 | msn.comDyadic International files to sell 3.35M shares for holdersApril 1, 2024 | msn.comDYAI: Capital Raise to Accelerate Near Term Revenue GrowthApril 1, 2024 | insidermonkey.comDyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call TranscriptMarch 30, 2024 | seekingalpha.comDyadic International, Inc. (DYAI) Q4 2023 Earnings Call TranscriptMarch 29, 2024 | finance.yahoo.comQ4 2023 Dyadic International Inc Earnings CallMarch 28, 2024 | benzinga.comRecap: Dyadic International Q4 EarningsMarch 28, 2024 | globenewswire.comDyadic Reports 2023 Full Year Results and Recent Company ProgressMarch 28, 2024 | globenewswire.comDyadic Announces Change in Board and Management Leadership RolesMarch 27, 2024 | globenewswire.comDyadic to Attend Industry Events in AprilMarch 26, 2024 | globenewswire.comDyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature CommunicationsMarch 21, 2024 | globenewswire.comDyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, CaliforniaMarch 14, 2024 | globenewswire.comDyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024March 11, 2024 | finance.yahoo.comDyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and CommercializationMarch 11, 2024 | globenewswire.comCORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and CommercializationSee More Headlines Receive DYAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dyadic International and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today5/15/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:DYAI CUSIPN/A CIK1213809 Webwww.dyadic.com Phone(561) 743-8333Fax561-743-8343Employees7Year FoundedN/APrice Target and Rating Average Stock Price Target$6.00 High Stock Price Target$6.00 Low Stock Price Target$6.00 Potential Upside/Downside+268.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,800,000.00 Net Margins-234.39% Pretax Margin-234.39% Return on Equity-81.57% Return on Assets-65.71% Debt Debt-to-Equity RatioN/A Current Ratio3.58 Quick Ratio3.58 Sales & Book Value Annual Sales$2.90 million Price / Sales16.43 Cash FlowN/A Price / Cash FlowN/A Book Value$0.20 per share Price / Book8.15Miscellaneous Outstanding Shares29,240,000Free Float20,817,000Market Cap$47.66 million OptionableOptionable Beta0.63 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Mark A. Emalfarb (Age 68)Founder, CEO, President & Director Comp: $636.61kMs. Ping Wang Rawson CPA (Age 48)M.B.A., Chief Financial Officer Comp: $279.07kMr. Doug Pace B.A.Executive Vice President of Business DevelopmentMs. Ana Gómez RodriguezSecretary of the BoardKey CompetitorsOKYO PharmaNASDAQ:OKYOIN8bioNASDAQ:INABCyclo TherapeuticsNASDAQ:CYTHQuince TherapeuticsNASDAQ:QNCXMiNK TherapeuticsNASDAQ:INKTView All CompetitorsInstitutional OwnershipCallan Capital LLCBought 27,174 shares on 5/3/2024Ownership: 0.093%View All Institutional Transactions DYAI Stock Analysis - Frequently Asked Questions Should I buy or sell Dyadic International stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dyadic International in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" DYAI shares. View DYAI analyst ratings or view top-rated stocks. What is Dyadic International's stock price target for 2024? 1 analysts have issued twelve-month price targets for Dyadic International's shares. Their DYAI share price targets range from $6.00 to $6.00. On average, they anticipate the company's share price to reach $6.00 in the next twelve months. This suggests a possible upside of 282.2% from the stock's current price. View analysts price targets for DYAI or view top-rated stocks among Wall Street analysts. How have DYAI shares performed in 2024? Dyadic International's stock was trading at $1.61 at the beginning of 2024. Since then, DYAI shares have decreased by 2.5% and is now trading at $1.57. View the best growth stocks for 2024 here. When is Dyadic International's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our DYAI earnings forecast. How were Dyadic International's earnings last quarter? Dyadic International, Inc. (NASDAQ:DYAI) posted its quarterly earnings data on Tuesday, May, 14th. The biotechnology company reported ($0.07) earnings per share for the quarter. The biotechnology company had revenue of $0.33 million for the quarter. Dyadic International had a negative trailing twelve-month return on equity of 81.57% and a negative net margin of 234.39%. During the same quarter last year, the company posted ($0.03) EPS. What other stocks do shareholders of Dyadic International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Dyadic International investors own include Silvercorp Metals (SVM), Endeavour Silver (EXK), Hecla Mining (HL), Pfizer (PFE), Advanced Micro Devices (AMD), Endeavour Silver (EDR), Mandalay Resources (MND), Alibaba Group (BABA) and Chimerix (CMRX). Who are Dyadic International's major shareholders? Dyadic International's stock is owned by many different institutional and retail investors. Top institutional investors include Callan Capital LLC (0.09%). Insiders that own company stock include Francisco Trust Under Agreemen, Mark A Emalfarb, Ping Wang Rawson and Ronen Tchelet. View institutional ownership trends. How do I buy shares of Dyadic International? Shares of DYAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DYAI) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersHow to Make 100X on the AI BoomInvestorPlaceShocking $16T Elon Musk Crypto LeakCrypto 101 MediaAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsDems have chosen Biden replacement?Paradigm PressRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyadic International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
